Framework discussion on domestic drug anti-counterfeiting plan

This content was submitted directly to this website by the supplier.

India’s Joint Secretary, Ministry of Health & Family Welfare, K.L. Sharma, will be the Guest of Honour and Keynote Speaker at UNIQUITY India 2016, where he will discuss the unfolding framework for an anti-counterfeiting plan concerning the Indian domestic drug supply. The event is hosted by Systech International, the global leader in serialization, track-and-trace, and regulatory compliance. Systech’s one-day conference will provide customers, industry leaders, and equipment manufacturers with a firm understanding of the many complex regulatory mandates that are quickly unfolding in India and around the world, as well as effective technologies to meet those demands. The event will take place October 6, 2016 at the ITC Maratha Hotel in Mumbai.

In his current position as Joint Secretary at the Ministry of Health and Family Welfare, Mr. Sharma is responsible for spearheading a number of key initiatives related to drug and food regulation. The title of his UNIQUITY talk is: Toward Developing an Effective Framework to Protect the Indian Domestic Drug Supply. He will talk about the Ministry's views on protecting the Indian population from the menace of counterfeit drugs, building on the program already introduced for medicines made in India for export markets. Additionally, Mr. Sharma will discuss the role of the central government on protecting Indian citizens against counterfeit drugs through application of robust technologies that empower consumers, while ensuring it is both cost-effective to small industry and ultimately successful.

India has been a global leader in the fight against counterfeit and spurious drugs. It was among the first major nations to deploy a serialization program in 2011 for the protection of Indian-made drugs that are exported to the rest of the world. This event set in motion a parallel approach for the domestic market. A Task Force was convened to advise the Health Ministry on the optimal path to actualize an effective program. Dr. Hemant Koshia, FDCA Commissioner of Gujarat, chaired that Task Force and will be a Special Guest at UNIQUITY where he will also give a talk on his perspectives on protecting the domestic drug supply.

The Indian pharmaceutical industry — from SMEs to MNCs — will need technology solutions that provide cost-effective regulatory compliance that ensures total risk mitigation. Complex supply chain regulations will put substantial pressure on these manufacturers, and therefore they will need long-term and effective solutions beyond machinery to safeguard their business.

Register for UNIQUITY India at

More in Home